For patients undergoing heart surgery, the incidence of post-operative atrial fibrillation (POAF) can be close to 50%, depending on the type of surgery and patient characteristics. ​

That makes POAF the leading complication of cardiac surgery and brings the risk of adverse acute and long-term clinical outcomes including longer hospital and ICU stay.​

What’s being explored to help those patients?​

The BoxX-NoAF trial is evaluating the safety and effectiveness of surgical ablation and left atrial appendage management in non-Afib cardiac surgery patients to reduce the incidence of POAF and long-term clinical Afib.

Richard Whitlock

<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cardiacsurgery&highligh…; target='_blank'>#cardiacsurgery</a>